Share this post: ×

Head and Neck Lymphedema: Recognizing Symptoms, Assessing Function, and Exploring Treatment Options

An educational resource for people affected by head and neck cancer, their families, and the clinicians who support them. Images and graphics are generously provided by Tactile Medical®

Head and neck cancer treatment can save lives, but its effects may continue long after treatment ends. One often overlooked complication is head and neck lymphedema, a condition that can cause swelling, tissue changes, discomfort, and difficulties with everyday activities such as swallowing, speaking, breathing, and moving the neck.

Lymphedema is not simply a cosmetic concern. It can affect physical function, social participation, emotional well-being, and quality of life. Fortunately, it can be assessed and managed, and a growing range of treatment options may help patients manage symptoms at home.

Understanding what to look for, how to seek an appropriate assessment, and which treatment options are available can help patients and clinicians take a more proactive approach to care.

What is lymphedema?

Lymphedema occurs when the lymphatic system cannot adequately transport lymphatic fluid away from the tissues. This fluid contains water, proteins, cellular debris, and other substances that normally circulate through the body’s tissues and lymphatic pathways.

When lymphatic drainage is impaired, fluid and other substances accumulate in the spaces between cells, known as the interstitium. Over time, this can contribute to swelling, inflammation, and fibrosis—the development of thickened, stiff, or scar-like tissue.

The lymphatic system plays an important role in maintaining fluid balance and supporting immune function. Lymphatic vessels collect excess tissue fluid and transport it through lymph nodes before returning it to the bloodstream.

More than one-third of the body’s lymph nodes are located in the head and neck. This extensive network is particularly vulnerable to damage from head and neck cancer and its treatment.

Why is head and neck lymphedema so common?

Head and neck cancer can affect lymphatic drainage through several mechanisms:

  • Tumors: Cancer may obstruct or disrupt lymphatic pathways.
  • Surgery: Removing lymph nodes or cutting lymphatic vessels can reduce the system’s ability to transport fluid.
  • Radiation therapy: Radiation can damage lymphatic vessels and surrounding tissues, leading to inflammation and scarring.
  • Fibrosis: As tissue becomes thicker and less flexible, normal fluid movement and tissue mobility may become more difficult.

Research has documented a substantial burden of lymphedema among head and neck cancer survivors, although reported rates vary depending on the population studied, the timing of assessment, and how lymphedema is defined. One frequently cited study found that approximately 90% of patients assessed 12 months after treatment had some degree of lymphedema, with many experiencing moderate or severe tissue changes.

Lymphedema may develop during treatment or emerge months or years later. It can also persist after cancer treatment has ended. For this reason, ongoing awareness and assessment are important throughout survivorship.

What are the signs and symptoms?

Head and neck lymphedema can affect both external structures, such as the face and neck, and internal structures, such as the oral cavity, pharynx, and larynx.

Symptoms vary considerably. Some people have obvious facial or neck swelling, while others experience internal swelling or tissue changes without noticeable external signs.

Common symptoms include:

  • Swelling of the face, jaw, chin, neck, or upper chest
  • A feeling of fullness, heaviness, tightness, or pressure
  • Reduced neck range of motion or difficulty turning the head
  • Skin tightness or changes in tissue texture
  • Pain, tenderness, tingling, or numbness
  • Thickened or hardened tissues associated with fibrosis
  • Changes in voice or difficulty speaking
  • Difficulty swallowing food, liquids, or saliva
  • A sensation of something being stuck in the throat
  • Breathing discomfort or changes in airway function

Not every symptom is caused by lymphedema. Scar tissue, muscle weakness, nerve injury, radiation-related changes, recurrent cancer, and other conditions can produce similar complaints. New or worsening symptoms therefore warrant appropriate clinical evaluation.

Why internal lymphedema matters

Swelling inside the throat may be particularly difficult to recognize because it cannot be seen simply by looking at a patient’s face or neck.

Internal edema may affect the tongue base, pharyngeal walls, epiglottis, aryepiglottic folds, and other structures involved in swallowing and airway protection. Depending on the location and severity, these changes may contribute to swallowing difficulties, altered voice quality, discomfort, or breathing concerns.

For speech-language pathologists (SLPs), this is an important clinical consideration: a patient may have persistent swallowing or voice complaints even when external swelling appears minimal.

Lymphedema can also coexist with other treatment-related impairments, making a comprehensive assessment essential.

How is head and neck lymphedema assessed?

Assessment should consider more than the visible amount of swelling. Clinicians need to understand where fluid and tissue changes are occurring, how severe they are, how they affect function, and whether other conditions may be contributing.

Depending on the patient’s symptoms and treatment history, assessment may involve a multidisciplinary team that includes an oncologist, otolaryngologist, SLP, physical or occupational therapist, certified lymphedema therapist, and other rehabilitation professionals.

1. Medical history and symptom screening

The assessment typically begins with a review of the patient’s cancer diagnosis, treatment history, and current concerns.

Clinicians may ask about:

  • Cancer site, stage, and treatment history
  • Previous neck dissection or other surgery
  • Radiation treatment and the timing of treatment
  • When swelling or other symptoms first appeared
  • Changes in swallowing, voice, breathing, or neck movement
  • Pain, tightness, skin changes, and daily activity limitations
  • Previous lymphedema treatment and response

A patient-reported symptom questionnaire can help identify concerns that might otherwise be overlooked. Screening is especially useful when patients describe persistent tightness, fullness, or functional changes but have little visible swelling.

2. External examination and measurements

Clinicians may inspect and palpate the face, jaw, neck, and upper chest to assess swelling and tissue characteristics.

Depending on the clinical setting, measurements may include:

  • Facial or neck circumferences
  • Standardized tape measurements at defined anatomical landmarks
  • Tissue thickness or volume estimates
  • Skin and tissue texture
  • Tissue softness, firmness, and mobility
  • Neck range of motion
  • Changes in appearance documented with standardized photographs

Repeated measurements can help clinicians monitor change over time and evaluate response to treatment. Consistency in measurement technique is important when comparing results across visits.

3. Assessment of internal lymphedema

When internal swelling is suspected, examination by an appropriate specialist may be necessary.

Flexible endoscopic evaluation: An otolaryngologist or appropriately trained clinician may use flexible endoscopy to visualize the pharynx and larynx. This can help identify edema, tissue changes, and other abnormalities.

Instrumental swallowing assessment: A modified barium swallow study, also called a videofluoroscopic swallowing study (VFSS), or a fiberoptic endoscopic evaluation of swallowing (FEES) may be appropriate when swallowing symptoms are present. These examinations evaluate swallowing physiology and safety; they can also provide information about relevant structural changes. They are not interchangeable with a dedicated lymphedema assessment.

Imaging and other measures: In selected cases, imaging or specialized measurement techniques may help characterize internal tissue swelling. Research is exploring ways to quantify internal lymphedema more objectively, although access and clinical protocols vary.

4. Assessing functional impact

The purpose of assessment is not simply to document edema. It is to understand how the condition affects the patient’s life.

For SLPs, relevant areas may include swallowing efficiency and safety, diet tolerance, secretion management, voice, speech, and patient-reported swallowing difficulty. Other clinicians may assess neck mobility, pain, skin integrity, and functional activities.

A patient may benefit from treatment even when the primary concern is not the appearance of swelling but the way tissue tightness or discomfort interferes with eating, communicating, sleeping, or participating in daily activities.

5. Ruling out other causes

New or rapidly worsening head and neck swelling should not automatically be attributed to lymphedema. Infection, blood clots, medication effects, cardiac or renal conditions, and recurrent or new cancer may require different management.

Rapid swelling, new difficulty breathing, noisy breathing, or inability to swallow saliva requires urgent medical evaluation. New or progressive swallowing or voice changes should also be assessed promptly.

How is head and neck lymphedema managed?

Lymphedema management is individualized. Treatment depends on the location and severity of swelling, the degree of fibrosis, the patient’s functional concerns, medical history, access to specialized care, and ability to maintain a home program.

A commonly used approach is complete decongestive therapy (CDT), which combines several conservative treatments. A qualified lymphedema therapist can help determine which components are appropriate for the head and neck.

Manual lymphatic drainage

Manual lymphatic drainage (MLD) is a specialized, gentle massage technique designed to encourage lymphatic fluid movement toward functioning drainage pathways.

Unlike conventional massage, MLD uses specific techniques and directional sequences. Because surgery and radiation can alter normal lymphatic routes, treatment should be tailored to the individual’s anatomy and medical history.

Patients may be taught selected self-drainage techniques to use at home. However, the head and neck can be challenging areas to treat independently, particularly when swelling extends across multiple anatomical regions or fibrosis is present.

Compression

Compression may help manage fluid accumulation in some patients. For head and neck lymphedema, options can include specially designed masks, garments, or wraps.

Not everyone tolerates compression equally well. Facial or neck garments may be uncomfortable, difficult to apply, or impractical for extended daily use. Compression must be selected and fitted appropriately, particularly for patients with airway concerns, sensitive or damaged skin, or complex surgical changes.

Exercise, movement, and skin care

Gentle movement and prescribed exercises can support mobility and function. Depending on the patient’s needs, rehabilitation may include neck range-of-motion exercises, postural work, and exercises addressing swallowing or other treatment-related impairments.

Skin care is also important because swelling and tissue changes can increase vulnerability to skin problems. Patients should follow their care team’s recommendations for skin hygiene, moisturization, and monitoring for redness, warmth, pain, or signs of infection.

Treatment of fibrosis and associated impairments

When fibrosis develops, tissues may become firm, less pliable, and more difficult to move. Management may include therapist-directed techniques, mobility exercises, and rehabilitation targeting specific functional limitations.

Lymphedema treatment does not replace swallowing rehabilitation, voice therapy, or other interventions when these are indicated. Instead, it may form part of a broader plan to address multiple overlapping effects of cancer treatment.

The importance of long-term management

Lymphedema is often a chronic condition. Treatment may reduce swelling and symptoms, but ongoing self-management is frequently needed to maintain benefits.

Unfortunately, access to specialized therapy can be difficult. Travel distance, cost, insurance coverage, limited availability of trained clinicians, and the time required for self-drainage or compression may prevent patients from receiving or continuing care.

These barriers make practical, sustainable home-treatment options an important area of interest in head and neck cancer rehabilitation.

Flexitouch® Plus: An at-home treatment option

The Flexitouch® Plus system, developed by Tactile Medical, is an advanced pneumatic compression device (APCD) designed to support lymphedema management. It is a home-use device that delivers sequential, programmed pressure through specialized garments.

Flexitouch Plus is FDA 510(k)-cleared for head and neck lymphedema treatment. It is designed to complement, rather than automatically replace, individualized clinical care.

How does it work?

The system uses inflatable chambers that fill and release in a programmed sequence. This creates a gentle, wave-like pattern of pressure intended to encourage lymphatic fluid movement toward functioning drainage pathways.

The head and neck garment is designed to direct fluid from the face and head toward the neck and from the neck and chest toward the underarm regions. The treatment sequence is intended to mimic key principles of manual lymphatic drainage.

A typical head and neck session takes approximately 32 minutes, according to the treatment protocol studied in clinical research. Patients are fitted for the garment and instructed in its use.

The device may be particularly helpful for patients who have difficulty performing self-manual lymphatic drainage or who face practical barriers to attending frequent in-person appointments.

However, a clinician should determine whether pneumatic compression is appropriate. Patients should receive device-specific instruction and follow the prescribed treatment plan, including any precautions related to their medical history.

What does the research show?

Research on advanced pneumatic compression for head and neck cancer-related lymphedema includes observational studies, smaller clinical investigations, and randomized controlled trials.

Immediate effects on internal and external swelling

A 2025 study published in Head & Neck evaluated 30 head and neck cancer survivors with a history of radiation treatment after one session of advanced pneumatic compression. Investigators found statistically significant immediate reductions in both external and internal lymphedema measurements. Participants also reported perceived benefits. The findings are encouraging, although the study was small and assessed immediate effects rather than long-term outcomes.

Read the study by Gregor and colleagues.

A multicenter randomized controlled trial

A larger trial published in Head & Neck in 2026 enrolled 236 people with head and neck cancer-related lymphedema who had not previously received lymphedema therapy. Participants received either daily Flexitouch Plus treatment or usual care, which included referral for therapist-guided treatment and home self-care.

At two months, both groups experienced similar reductions in lymphedema-related symptom burden and internal soft-tissue swelling. The Flexitouch Plus group had a statistically significant reduction in external swelling, whereas the usual-care group did not. These findings support pneumatic compression as a potential treatment option, while also showing that usual care can provide meaningful symptom improvement.

Read the randomized controlled trial by Murphy and colleagues.

Patient experience and long-term use

Studies have also examined treatment adherence, patient satisfaction, symptoms, and the practicality of home treatment. Such outcomes matter because a treatment’s real-world value depends not only on its physiological effects but also on whether patients can comfortably and consistently use it.

The broader evidence base is still developing. Research findings should be interpreted in light of each study’s design, sample size, outcome measures, and follow-up period. Results from a group of participants do not guarantee the same degree of improvement for every patient.

What benefits might patients experience?

Depending on the individual and the outcomes measured, treatment with an advanced pneumatic compression device may help with:

  • Reducing external swelling
  • Improving some measures of internal tissue edema
  • Relieving sensations of tightness, fullness, or discomfort
  • Supporting neck mobility
  • Making regular home treatment more manageable

Some studies have reported improvements in swallowing-related symptoms and other patient-reported outcomes. However, reduced swelling does not necessarily translate into improved swallowing safety or function for every patient. Patients with dysphagia may still require instrumental assessment and targeted swallowing rehabilitation.

How does Flexitouch Plus fit into a treatment plan?

For selected patients, pneumatic compression may be used alongside therapist-directed lymphedema care, self-management education, exercise, and rehabilitation for swallowing or other functional impairments.

A clinician can help determine whether the device is appropriate, establish treatment goals, and monitor progress using consistent measurements and patient-reported outcomes.

Practical considerations include comfort, the ability to apply and remove the garment, daily treatment time, device access, insurance coverage, and any relevant medical precautions. Patients should ask their clinicians and Tactile Medical about eligibility, coverage, costs, and the process for obtaining a device.

No single intervention is right for everyone. The goal is to identify a safe, effective, and sustainable approach that addresses the patient’s specific needs.

A multidisciplinary approach makes a difference

Head and neck lymphedema can affect several interconnected systems. Collaboration among oncology, otolaryngology, speech-language pathology, rehabilitation, and lymphedema experts can help ensure that swelling is not considered in isolation from the patient’s broader health and functional needs.

For clinicians, this means screening for lymphedema when appropriate, recognizing that internal swelling may be present without obvious external signs, and referring patients for specialized assessment when symptoms warrant further investigation.

For patients and caregivers, it means knowing that persistent swelling, tightness, swallowing changes, or reduced neck movement are worth discussing with the care team—even after cancer treatment has ended.

The bottom line

Head and neck lymphedema is a common and potentially debilitating consequence of head and neck cancer and its treatment. Early recognition, appropriate assessment, and individualized management can help patients address symptoms and preserve function.

Traditional approaches such as manual lymphatic drainage, compression, exercise, skin care, and rehabilitation remain important components of care. Advanced pneumatic compression devices, including Flexitouch Plus, offer an additional home-treatment option for selected patients, with emerging clinical evidence supporting their role in management.

Most importantly, persistent swelling and functional changes should not be dismissed as an inevitable part of cancer survivorship. Patients deserve assessment, access to appropriate treatment, and support in finding a management plan that fits their lives.

Educational disclaimer: This article is intended for general education and does not replace individualized medical advice, diagnosis, or treatment. Patients should consult their healthcare team before starting a lymphedema treatment program or using a compression device.

Downloadable Resources

References

  1. Gregor JW, Chang B, Keole N, McGary A, Patel S. Initial proof-of-concept study on immediate effects of external advanced pneumatic compression on pharyngeal and laryngeal internal lymphedema using a fluoroscopic measurement tool. Head & Neck. 2025;47(3):962–973. doi:10.1002/hed.27983.
  2. Murphy BA, Smith DK, Kline-Quiroz CM, et al. Short-term outcomes of advanced pneumatic compression device versus usual care therapy for head and neck cancer-related lymphedema: A multi-site randomized clinical trial. Head & Neck. 2026;48(4):1077–1087. doi:10.1002/hed.70155.
  3. The management of head and neck lymphoedema: A 2025 systematic review. https://pmc.ncbi.nlm.nih.gov/articles/PMC12434576/
  4. Ridner SH, et al. A prospective study of the lymphedema and fibrosis continuum in patients with head and neck cancer. Lymphatic Research and Biology. 2016;14(4):198–205. https://pubmed.ncbi.nlm.nih.gov/27305456/



Share this post: ×

Keep Eating: A Conversation with Dr. Ianessa Humbert

Presented by Ianessa Humbert, PhD, SLP


Wednesday, November 11th at 8pm Eastern | 5pm Pacific

continue reading →


Share this post: ×

Dysphagia Research at a Crossroads

What Happened. The National Institute on Deafness and Other Communication Disorders (NIDCD) recently issued FY2026 guidance indicating that grant applications whose primary focus is dysphagia, where communication is not impacted, will no longer be considered within its mission area. While NIDCD has funded important dysphagia research for many years and remains a valued partner, this development highlights a longstanding challenge: dysphagia does not have a clearly defined federal research home despite affecting millions of Americans.

Why It Matters. Millions of Americans live with swallowing disorders resulting from stroke, head and neck cancer, neurodegenerative diseases, developmental disorders, critical illness, aging, and other conditions. Dysphagia can lead to malnutrition, dehydration, aspiration pneumonia, social isolation, caregiver burden, and increased healthcare costs. Reduced research attention threatens progress toward better prevention, diagnosis, treatment, and quality of life.

The Bigger Problem. This moment did not create the problem—it revealed it. Dysphagia falls across multiple diseases and medical specialties, making it difficult to fit within existing federal research structures. As a result, swallowing disorders have lacked a coordinated national strategy despite their significant health and economic impact. We believe this challenge requires a long-term solution that extends beyond any single NIH agency or institute.

Call for Community Input. To help inform future advocacy efforts, we are gathering information from patients, caregivers, clinicians, researchers, and industry partners. We invite individuals to share their contact information, their connection to dysphagia, and how swallowing disorders have affected their lives, research, clinical practice, or organization. These stories and experiences will help demonstrate the real-world consequences of inadequate federal attention to swallowing disorders.

Looking Backwards. In 2025, the NFOSD partnered with the Thyroid, Head, and Neck Cancer Foundation to host a meeting with the FDA. The purpose of the meeting was to amplify the voice of the patient to help the FDA and other key stakeholders better understand the lived experience of those with dysphagia and its impact on daily life. If you would more information, view the Voice of the Patient Report.

How To Help. Tell us how dysphagia has impacted you, your patients, and your research by completing the survey below. Together, we will work toward a future in which swallowing disorders receive the recognition they deserve, including exploring federal policy solutions that could establish a national strategy for improving dysphagia research, education, and awareness.

This initiative is supported by the following organizations

(This initiative is organized by the National Foundation of Swallowing Disorders)



Share this post: ×

A Letter to Our Community

A Letter to Our Community from
NFOSD President, Ed Steger


As we enter the month of June, I am proud to announce the start of Dysphagia Awareness Month, a statute passed by Congress in 2008 to shine a light on the millions of individuals living with swallowing disorders — myself included.

This year, I’m writing to you not only as President of the National Foundation of Swallowing Disorders, but also as someone who continues to personally navigate the realities of dysphagia every single day. Over the past year, my own health challenges have deepened my understanding of what so many in our community experience — the physical, emotional, and social impact of swallowing disorders, and the resilience it takes to keep moving forward.

As I reflect on this year’s Awareness Month, I am especially grateful for the privilege of serving this community. Watching the NFOSD increase dysphagia awareness, support important research initiatives, and grow into a source of patient/caregiver education, advocacy, support, and hope for so many has been both a gift and an honor. While the future may bring new transitions for me personally, my belief in this mission — and in the strength of this community — has never been greater.

Dysphagia is more than a medical condition. It affects nutrition, health, communication, relationships, mental well-being, and quality of life. It can result from stroke, neurodegenerative disease, head and neck cancer, trauma, congenital disorders, aging, and countless other conditions. Yet despite impacting millions, dysphagia remains under-recognized and under-discussed.

This June, we are proud to once again elevate the voice of the dysphagia community through awareness campaigns, educational initiatives, support programs, advocacy efforts, and opportunities to connect with others who understand the journey firsthand. I encourage you to join us throughout the month and help us continue building awareness and compassion for those impacted by swallowing disorders.

To our members, volunteers, healthcare professionals, caregivers, industry partners, and sponsors: thank you. Your support fuels our mission and reminds every person facing dysphagia that they are not alone.

Let’s make this month a time of action, connection, education, and hope — and continue working toward a future where every individual impacted by dysphagia has access to the treatment, understanding, and support they require.

 With warm regards,
Ed Steger
President, National Foundation of Swallowing Disorders
Head and Neck Cancer Survivor
Ed@nfosd.com

P.S. If you are not already an annual member, please consider becoming an NFOSD member (suggested donations: patients/caregivers ($10/year); healthcare professionals ($50/year)). Your support helps us continue our mission of making life better for all those impacted by dysphagia. Click here to sign up for your 2026 membership.



Share this post: ×

Swallowing Against the Odds: My Journey with Dysphagia

By Danny Voyes

My name is Danny, and to say that I’ve had a long and complicated history with dysphagia is an understatement! This is my story:

continue reading →